Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Agnieszka Gierczak-Pachulska"'
Autor:
Agnieszka Gierczak-Pachulska, Michał Kaza, Katarzyna Jarus-Dziedzic, Olga Czerepow-Bielik, Agnieszka Segiet-Święcicka, Grzegorz Huszcza, Katarzyna Sidoruk, Daniel Rabczenko, Piotr J. Rudzki
Publikováno v:
Acta Poloniae Pharmaceutica, Vol 81, Iss 1, Pp 97-108 (2024)
Rivaroxaban is an oral anticoagulant that is a selective, direct factor Xa inhibitor. It is used to prevent thrombotic events of atherosclerotic etiology and to prevent stroke and peripheral embolism in adult patients with nonvalvular atrial fibrilla
Externí odkaz:
https://doaj.org/article/316b5d2cc8424ab39a49b99e3bb9ff89
Autor:
Maciej Wieczorek, Piotr J. Rudzki, Katarzyna Jarus-Dziedzic, Agnieszka Gierczak-Pachulska, Katarzyna Bazydlo-Guzenda
Publikováno v:
Diabetes. 70
Activation of GPR40 (G-protein coupled receptor 40) in pancreatic β-cells may improve glycaemic control in type 2 diabetes (T2D) patients through enhancement of glucose-stimulated insulin secretion (GSIS). Here we present phase I an open label, dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75efd9bc7868cfd71884ec874298ca33
https://doi.org/10.2337/db21-761-p
https://doi.org/10.2337/db21-761-p